Company > Profile

Dr Martin Edwards

Non-Executive Director

Martin is Senior Partner at Novo Ventures, the venture capital arm of Novo. He is chairman of Vantia Ltd and NeRRe Therapeutics Ltd and a director on the boards of Tarsa Therapeutics Inc., KalVista Ltd, CoLucid Inc, Karus Ltd and E3 Bio Ltd. Prior to this, Martin was CEO of ReNeuron Ltd from 1998 to 2003, taking the company public in 2001. He was worldwide head of drug development for Novo Nordisk from 1994 to 1998, senior vice president at Novo Nordisk (USA) from 1992 to 1994 and CMO/Vice President at Zymogenetics from 1989 to 1992.

< back to Board